Worldwide Diagnostic Specialty Antibodies Industry to 2029 – Featuring Abcam, Agilent Technologies and Santa Cruz Biotechnology Among Others – ResearchAndMarkets.com – QNT Press Release

[ad_1]

The “Diagnostic Specialty Antibodies Market by Type, Clonality, Technique, Conjugate, and Application – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The diagnostic specialty antibodies market is expected to grow at a CAGR of 4.6% from 2022-2029 to reach $39.99 billion by 2029.

Following a comprehensive primary and secondary research and an in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities. The growth of the diagnostic specialty antibodies market is mainly attributed to the growing prevalence of diseases worldwide and the burden imposed on the people by these diseases, the rising incidences of unintended pregnancies, the increasing availability of funding for researchers with the use of diagnostic antibodies, and the increasing number of regulatory approvals of test kits containing diagnostic antibodies.

In addition to this, the high prevalence of diseases in emerging countries and the growing number of initiatives by public and private organizations supporting diagnosis activities to eradicate infectious diseases are expected to provide significant opportunities for the growth of this market during the forecast period.

An in-depth analysis of the geographical scenario of the diagnostic specialty antibodies market provides detailed qualitative …

Full story available on Benzinga.com

[ad_2]

Source link